-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VrTyyT6O9dQKYlYQl9ik+V2spwBn8SM+HJUaKtb76LY1PXwd2peZzt8GMY6KTezs xzA30R7grWqDNGYWCmnnrA== 0001047469-98-032435.txt : 19980824 0001047469-98-032435.hdr.sgml : 19980824 ACCESSION NUMBER: 0001047469-98-032435 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980821 SROS: AMEX SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ CENTRAL INDEX KEY: 0000819689 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 720925679 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-40548 FILM NUMBER: 98695897 BUSINESS ADDRESS: STREET 1: 5910 COURTYARD DR #300 CITY: AUSTIN STATE: TX ZIP: 78731 BUSINESS PHONE: 5123436912 MAIL ADDRESS: STREET 1: 5910 COURTYARD DR STREET 2: STE 300 CITY: AUSTIN STATE: TX ZIP: 78731 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CHAMBERS RUSSELL C CENTRAL INDEX KEY: 0001060270 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 772 POTATO PATCH CITY: VAIL STATE: CO ZIP: 81652 BUSINESS PHONE: 9704763386 MAIL ADDRESS: STREET 1: 772 POTATO PATCH CITY: VAIL STATE: CO ZIP: 81652 SC 13D 1 SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* --------- Arrhythmia Research Technology, Inc. -------------------------------------------------------- (Name of Issuer) Common Stock, Par Value $.01 -------------------------------------------------------- (Title of Class of Securities) 042698209 -------------------------------------------------------- (CUSIP Number) Russell C. Chambers, 772 Potato Patch, Vail, Colorado 81657 (512)343-6912 ------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 21, 1998 -------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box / /. NOTE: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) Page 1 of 5 Pages --- CUSIP No. 042698209 13D Page 2 of 5 Pages --------- --- --- - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Russell C. Chambers - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) / / of a Group* (b) / / - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Source of Funds* PF - ------------------------------------------------------------------------------- (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- (6) Citizenship or Place of Organization U.S. - ------------------------------------------------------------------------------- Number of Shares (7) Sole Voting 299,450 Shares Common Beneficially Owned Power Stock, $.01 Par Value by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power N/A -------------------------------------------------- (9) Sole Dispositive 299,450 Shares Common Power Stock, $.01 Par Value -------------------------------------------------- (10) Shared Dispositive N/A Power - ------------------------------------------------------------------------------- (11) Aggregate Amount Beneficially Owned by Each Reporting Person 299,450 Shares Common Stock, $.01 Par Value - ------------------------------------------------------------------------------- (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------- (13) Percent of Class Represented by Amount in Row (11) 8.4% - ------------------------------------------------------------------------------- (14) Type of Reporting Person* IN - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 042698209 Page 3 of 5 Pages --------- --- --- ITEM 1. SECURITY AND ISSUER This statement relates to the $.01 Par Value Common Stock ("Common Stock") of Arrhythmia Research Technology, Inc. ("ART"), the principal executive offices of which are located at 5910 Courtyard Drive, Suite 300, Austin, Texas 78731. ITEM 2. IDENTITY AND BACKGROUND (a) Russell C. Chambers, MD (b) Dr. Chambers' business address is 772 Potato Patch, Vail, Colorado 81657. (c) Dr. Chambers' principal occupation is overseeing his personal investments. (d) Dr. Chambers has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years. (e) Dr. Chambers has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction the result of which was a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws during the last five years. (f) Dr. Chambers is a citizen of the United States. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION The Common Stock of ART has been purchased for an aggregate cash consideration of $76,150.00 utilizing personal funds. ITEM 4. PURPOSE OF TRANSACTION Dr. Chambers has purchased and sold the Common Stock of ART for investment purposes. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER CUSIP No. 042698209 Page 4 of 5 Pages --------- --- --- (a) The aggregate number of shares of Common Stock of ART beneficially owned by Dr. Chambers and the percentage which those shares are of the outstanding Common Stock of ART are as follows: Russell C. Chambers 299,450 shares 8.4% (b) Dr. Chambers has the sole power to vote and the sole power to dispose or direct the disposition of all of the shares of Common Stock listed in subpart (a) of this Item. (c) The following transactions in the Common Stock of ART were effected by Dr. Chambers within the last sixty days:
DATE AMOUNT OF SECURITIES PRICE PER SHARE WHERE AND HOW EFFECTED - ---- -------------------- --------------- ---------------------- 7/31/98 200 Shares $1-1/4 Open Market 8/6/98 10,000 Shares $1-3/16 Open Market 8/7/98 5,000 Shares $1-3/16 Open Market 8/10/98 200 Shares $1-1/8 Open Market 8/11/98 10,000 Shares $1-1/16 Open Market 8/12/98 15,000 Shares $1 Open Market 8/13/98 1,600 Shares $1-1/8 Open Market 8/13/98 10,000 Shares $1 Open Market 8/13/98 1,000 Shares $1-1/16 Open Market 8/17/98 7,900 Shares $1-1/4 Open Market 8/20/98 8,000 Shares $1-3/16 Open Market
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER Dr. Chambers does not have any contracts, arrangements, understandings, or relationships (legal or otherwise) with any persons with respect to any securities of ART, including but not limited to transfer or voting of any securities of ART; finders fees; joint ventures; loan or option arrangements; puts or calls; guarantees of profits; divisions of profits or losses; or the giving or withholding of proxies. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS Not applicable. CUSIP No. 042698209 Page 5 of 5 Pages --------- --- --- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. August 21, 1998 ---------------------------------------- (Date) /s/ Russell C. Chambers ---------------------------------------- (Signature) Russell C. Chambers ---------------------------------------- (Name/Title) -----END PRIVACY-ENHANCED MESSAGE-----